U.S. markets closed

  • S&P 500

    4,436.52
    +7.42 (+0.17%)
     

  • Dow 30

    35,208.51
    +144.26 (+0.41%)
     

  • Nasdaq

    14,835.76
    -59.36 (-0.40%)
     

  • Russell 2000

    2,247.76
    +11.75 (+0.53%)
     

  • Crude Oil

    67.83
    -1.26 (-1.82%)
     

  • Gold

    1,763.50
    -45.40 (-2.51%)
     

  • Silver

    24.33
    -0.96 (-3.80%)
     

  • EUR/USD

    1.1767
    -0.0070 (-0.59%)
     

  • 10-Yr Bond

    1.2900
    +0.0730 (+6.00%)
     

  • GBP/USD

    1.3873
    -0.0058 (-0.41%)
     

  • USD/JPY

    110.2330
    +0.4800 (+0.44%)
     

  • BTC-USD

    42,589.35
    +1,676.20 (+4.10%)
     

  • CMC Crypto 200

    1,045.40
    +55.76 (+5.63%)
     

  • FTSE 100

    7,122.95
    +2.52 (+0.04%)
     

  • Nikkei 225

    27,820.04
    +91.94 (+0.33%)
     

Immunovant to Report Financial Results for Quarter Ended June 30, 2021

  • Oops!
    Something went wrong.
    Please try again later.
Immunovant
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that it will host a conference call and audio webcast on Monday, August 9, 2021 at 8 a.m. ET to discuss financial results for its fiscal first quarter ended June 30, 2021.

Following prepared remarks, the call will include a live question-and-answer session for the investment community. To access the webcast, please visit Immunovant’s website at www.immunovant.com.

Participants may also dial in using the numbers provided below:

Toll Free: 1-877-407-9039
Toll/International: 1-201-689-8470

An archived webcast recording will be available on Immunovant’s website for a limited time.

About Immunovant, Inc.
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.

Contact:
Tom Dorney
Investor Relations
Immunovant, Inc.
info@immunovant.com


Recommended Stories

  • Why Shares of FireEye Were Down 16% Today

    Earnings weren't bad, but the spin-off of its products segment makes for an uncertain path in the short term.

  • Why Sunrun Stock Got Eclipsed Today

    Shares of Sunrun (NASDAQ: RUN), the self-proclaimed "nation's leading provider of residential solar, storage and energy services," had fallen 9.9% as of 1:20 p.m. EDT after the company reported a big earnings miss -- and a change of management. For Q2 2021, Sunrun says it grew its customer count 19% year over year to just under 600,000 customers. Unfortunately, the cost of that revenue grew 124%, pushing operating losses higher, and leaving Sunrun with a $0.20-per-share loss on the bottom line -- nearly twice as bad as the $0.11 loss a year ago.

  • Here's Why Palantir Technologies Stock Sank 17.6% Last Month

    Shares of Palantir Technologies (NYSE: PLTR) sank 17.6% in July, according to data from S&P Global Market Intelligence. Despite debuting a new product offering for its Foundry data analytics platform and announcing continued collaboration with the U.S. government on vaccine distribution projects, the stock lost ground amid market volatility. With concerns related to faster-than-anticipated inflation and the coronavirus delta variant, investors shied away from riskier tech stocks, and Palantir ended the month down double digits as a result of these trends.

  • Here's Why Universal Display Stock Crashed on Friday

    Shares of Universal Display (NASDAQ: OLED) fell as much as 13.5% on Friday, bouncing off that bottom near 11:15 a.m., EDT. The developer and reseller of technologies and materials for organic light-emitting diode (OLED) panels reported mixed second-quarter results on Thursday evening. Universal Display's second-quarter sales surged 124% year over year, landing at $130 million.

  • 15 Best Electric Car Stocks to Buy Now

    In this article we will take a look at the 15 best electric car stocks to buy now. You can skip our detailed analysis of the EVs industry’s outlook for 2021, and go directly to the 5 Best Electric Car Stocks to Buy Now. There is hardly any doubt that in a few decades, at […]

  • 3 Top Artificial Intelligence Stocks to Buy in August

    Artificial intelligence systems have become a critical ingredient in the tech sector's recipe for growth, with applications that help boost the capabilities of everything from search engines to autonomous vehicles. Investors looking to profit from the ever-increasing use of AI might want to take a close look at companies like Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG), Palo Alto Networks (NYSE: PANW), and Qualcomm (NASDAQ: QCOM).

  • Why Plug Power Jumped 10% Friday Morning, but Then Retreated

    Hydrogen fuel cell company Plug Power (NASDAQ: PLUG) reported its second-quarter 2021 financial report after the bell Thursday, and investors gave the stock an early boost today. Plug reported that compared to the year-ago period, net revenue increased 83% in its second quarter ended June 30. As a result, the company said in its conference call with investors, it raised estimates for the full year 2021 for gross billings to $500 million, a 50% jump over 2020.

  • Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks of 2021?

    The Dow Jones Industrial Average (DJINDICES: ^DJI) may be up a tidy 15% so far this year, but not all 30 of the Dow stocks have logged gains. The Dow's worst year-to-date performers are also now its top prospects. The three companies in question are Verizon (NYSE: VZ), Walt Disney (NYSE: DIS), and Merck (NYSE: MRK), with stock prices in 2021 down 5.9%, 2.5%, and 3.1%, respectively.

  • Why MP Materials Stock Just Popped

    Shares of MP Materials (NYSE: MP), a miner of rare earth elements, are up 3.3% at 11:15 a.m. EDT Friday after crushing Q2 earnings estimates yesterday afternoon. The bad news is that at one point this morning, MP shares were up as much as 12.5%, so it actually looks as if the enthusiasm over this rare earth metals stock is dying out fast. Heading into Q2, analysts had forecast that MP Materials would earn a $0.13-per-share profit on sales of $58.3 million.

  • Why the Nasdaq's Hydrogen Fuel Cell Stocks Just Charged Up

    The stock market was generally up on Friday, but the Nasdaq Composite (NASDAQINDEX: ^IXIC) didn't get to join in the fun. As of just before 11 a.m. EDT, the Nasdaq was down more than half a percent, even though just about every other major market benchmark was up on the day. Hydrogen fuel cell stocks got a lift on favorable earnings and other factors, and below, we'll look more closely at some of the most popular companies in the space.

  • Why Appian Tumbled 15% in July

    Shares of Appian (NASDAQ: APPN) fell by 15.5% last month, according to data provided by S&P Global Market Intelligence, on no company-specific news. The sell-off may have come as investors pulled back some of their optimism about the company from the previous month when they drove Appian's share price up more than 50%. Investors have, generally speaking, sold off some high-growth technology stocks earlier this year, after pouring into the sector in 2020.

  • Why Redfin Was Sinking on Friday Despite Q2 Beats

    Investors were leaving Redfin's (NASDAQ: RDFN) house at the end of the week. On Friday, the prominent online real estate company posted its latest set of quarterly figures, and the stock promptly traded down. On a year-over-year basis in its second quarter, Redfin managed to more than double its revenue to $471 million.

  • Is Alibaba a Buy Following Mixed Earnings? Analyst Weighs In

    Ahead of Alibaba’s (BABA) F1Q22 earnings, the common thread running through analysts’ projections was that the ecommerce giant’s investments would weigh on the quarter’s display. And so it proved to be. The company delivered a mixed set of results that are adding more pressure to shares, already under the cosh by constant battles with the Chinese authorities. Although there was a beat on the bottom-line as Non-GAAP EPS of CNY16.60 came ahead of the Street’s forecast by CNY2.31, the company faile

  • Why Roblox Stock Fell 14% in July

    Shares of Roblox (NYSE: RBLX), a gaming platform, fell by 14.5% last month, according to data provided by S&P Global Market Intelligence, as investors continued to look beyond so-called pandemic plays and after the company's stock received a sell rating from an analyst. Roblox's stock began falling in mid-July after Benchmark analyst Mike Hickey initiated coverage of the tech company with a price target of $75 and a sell rating on the stock. Investors have likely also sold Roblox recently because the company was viewed by some as a good investment during the pandemic as more people spent time at home during lockdowns and social distancing.

  • Boston Beer (NYSE:SAM) Missed Earnings and Issued a Lower Outlook. The Company is Still Growing and May Present an Opportunity

    The Boston Beer Company, Inc. (NYSE:SAM) just released its latest quarterly report and things are not looking great. The price dropped from US$947 to US$700 shortly after, and investors kept selling off as the stock not trades around high US$650s. Let's go over what happened and what to expect moving forward.

  • 10 Tech Penny Stocks Reddit is Buying

    In this article, we discuss the 10 tech penny stocks Reddit is buying. If you want to skip our detailed analysis of these stocks, go directly to the 5 Tech Penny Stocks Reddit is Buying. Technology stocks have reached evaluations that many analysts now term sky-high and in dire need of correction. Of the top […]

  • What investors are watching following Robinhood’s IPO

    Brianne Lynch, Business Development & Partnerships at EquityZen, joins Yahoo Finance to discuss what lies ahead for Robinhood and its investors.

  • 10 High Yield Dividend Stocks to Buy in August

    In this article, we will be looking at 10 high yield dividend stocks to buy in August. If you want to skip our detailed analysis of dividend investing, you can go directly to the 5 High Yield Dividend Stocks to Buy in August. As we enter into a new month this year, it is only […]

  • Why Shares of Lumen Technologies Tumbled 8.8% Today

    Shares of Lumen Technologies (NYSE: LUMN) (formerly CenturyLink) were down 8.8% at market close on Wednesday. The tumble in share price followed the company's second-quarter 2021 earnings update, which showed a 5% year-over-year decline in revenue to $4.92 billion, but a 34% increase in free cash flow to $993 million. Lumen remains highly profitable, but its sales have been stuck in stubborn decline for years as legacy telecom services slowly but steadily lose value over time.

  • Why Amedisys Stock Is Crashing Today

    What happened Shares of Amedisys (NASDAQ: AMED) were down 21.2% as of 11:29 a.m. EDT on Thursday. The big decline came after the home health and hospice company announced its second-quarter results following the market close on Wednesday.